AU5115393A - Novel derivatives of taxol analogues, preparation thereof and compositions containing them - Google Patents

Novel derivatives of taxol analogues, preparation thereof and compositions containing them

Info

Publication number
AU5115393A
AU5115393A AU51153/93A AU5115393A AU5115393A AU 5115393 A AU5115393 A AU 5115393A AU 51153/93 A AU51153/93 A AU 51153/93A AU 5115393 A AU5115393 A AU 5115393A AU 5115393 A AU5115393 A AU 5115393A
Authority
AU
Australia
Prior art keywords
preparation
compositions containing
novel derivatives
taxol analogues
taxol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51153/93A
Inventor
Jean-Dominique Bourzat
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU5115393A publication Critical patent/AU5115393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
AU51153/93A 1992-10-05 1993-10-04 Novel derivatives of taxol analogues, preparation thereof and compositions containing them Abandoned AU5115393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9211744 1992-10-05
FR9211744A FR2696461B1 (en) 1992-10-05 1992-10-05 New derivatives of taxol analogs, their preparation and compositions containing them.
PCT/FR1993/000970 WO1994007880A1 (en) 1992-10-05 1993-10-04 Novel derivatives of taxol analogues, preparation thereof and compositions containing them

Publications (1)

Publication Number Publication Date
AU5115393A true AU5115393A (en) 1994-04-26

Family

ID=9434122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51153/93A Abandoned AU5115393A (en) 1992-10-05 1993-10-04 Novel derivatives of taxol analogues, preparation thereof and compositions containing them

Country Status (5)

Country Link
AU (1) AU5115393A (en)
FR (1) FR2696461B1 (en)
MX (1) MX9305769A (en)
WO (1) WO1994007880A1 (en)
ZA (1) ZA937321B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511762A (en) 1993-07-19 2003-09-26 Univ British Columbia Anti-angiogenic compositions and methods of use
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
ATE196844T1 (en) * 1996-05-22 2000-10-15 Protarga Inc COMPOSITIONS CONTAINING CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
WO1998013359A1 (en) * 1996-09-24 1998-04-02 Marigen S.A. Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
EP1418945A2 (en) 2001-03-13 2004-05-19 Angiotech Pharmaceuticals, Inc. Micellar drug delivery vehicles and uses thereof
EP1800670A1 (en) 2001-04-20 2007-06-27 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2005016241A2 (en) 2003-05-16 2005-02-24 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
PE20050693A1 (en) 2004-02-13 2005-09-27 Univ Florida State Res Found TAXANS REPLACED WITH CYCLOPENTIL ESTERS IN C10
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006089209A2 (en) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
EP3056196A1 (en) 2006-03-22 2016-08-17 SynCore Biotechnology CO., LTD Treatment of triple receptor negative breast cancer
WO2008005284A2 (en) 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
JP2011517455A (en) 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C (10) ethyl ester and C (10) cyclopropyl ester substituted taxanes
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
CA2724550C (en) 2008-05-22 2017-01-03 Kereos, Inc. Combination antitumor therapy
US20110172293A1 (en) 2008-07-08 2011-07-14 Fish Jason E Methods and Compositions for Modulating Angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
CN104582717B (en) 2012-07-19 2018-03-13 雷德伍德生物科技股份有限公司 There are specific antibody and its application method to CD22
WO2014074218A1 (en) 2012-11-12 2014-05-15 Redwood Bioscience, Inc. Compounds and methods for producing a conjugate
CN105142677B (en) 2013-02-15 2019-08-30 加利福尼亚大学董事会 Chimeric antigen receptor and its application method
JP6410790B2 (en) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Mitochondrial aldehyde dehydrogenase-2 modulator and method of use thereof
WO2015081282A1 (en) 2013-11-27 2015-06-04 Redwood Bioscience, Inc. Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
DK3107899T3 (en) 2014-02-19 2020-11-16 Aviv Therapeutics Inc MITOCONDRIAL ALDEHYDE HYDROGENASE 2 (ALDH2) -BINDING POLYCYCLIC AMIDES AND ITS USE FOR CANCER TREATMENT
JP6877049B2 (en) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク．Ｚｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． Drug formulation based on granules containing polysaccharide-vitamin conjugate
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
TWI760319B (en) 2015-12-30 2022-04-11 杏國新藥股份有限公司 Treatment of breast cancer
JP2019515677A (en) 2016-04-26 2019-06-13 アール．ピー．シェーラー テクノロジーズ エルエルシー Antibody conjugates and methods of making and using the same
AU2017299374B2 (en) 2016-06-01 2021-05-27 Servier IP UK Limited Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
TW201825087A (en) 2017-01-05 2018-07-16 杏國新藥股份有限公司 Treatment of pancreatic cancer
US20190367621A1 (en) 2017-01-18 2019-12-05 F1 Oncology, Inc. Chimeric antigen receptors against axl or ror2 and methods of use thereof
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
CA3090129A1 (en) 2018-01-31 2019-08-08 Galera Labs, Llc Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
WO2019200181A1 (en) 2018-04-11 2019-10-17 Ohio State Innovation Foundation Methods and compositions for sustained release microparticles for ocular drug delivery
EP3823674A4 (en) 2018-07-18 2022-12-28 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
TW202038994A (en) 2019-01-14 2020-11-01 美商醫格耐免疫治療公司 Recombinant vaccinia virus and methods of use thereof
CA3129883A1 (en) 2019-02-14 2020-08-20 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
AU2020253449A1 (en) 2019-04-02 2021-11-18 Kenjockety Biotechnology, Inc. Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
JP2021106576A (en) 2019-12-12 2021-07-29 イグナイト・イミュノセラピー，インコーポレーテッド Variant oncolytic vaccinia virus and methods of use thereof
MX2022009355A (en) 2020-01-29 2022-09-02 Kenjockety Biotechnology Inc Anti-mdr1 antibodies and uses thereof.
CN116323662A (en) 2020-06-04 2023-06-23 肯乔克蒂生物技术股份有限公司 anti-ABCG 2 antibodies and uses thereof
CN116529267A (en) 2020-06-04 2023-08-01 肯乔克蒂生物技术股份有限公司 ABCG2 efflux pump-cancer antigen multispecific antibodies and related compositions, reagents, kits and methods
EP4182335A2 (en) 2020-07-14 2023-05-24 Pfizer Inc. Recombinant vaccinia virus
CN116490522A (en) 2020-09-02 2023-07-25 肯乔克蒂生物技术股份有限公司 anti-ABCC 1 antibodies and uses thereof
AU2021380659A1 (en) 2020-11-13 2023-06-01 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
WO2023114658A1 (en) 2021-12-13 2023-06-22 Kenjockety Biotechnology, Inc. Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX9102128A (en) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2696461B1 (en) 1994-11-10
WO1994007880A1 (en) 1994-04-14
FR2696461A1 (en) 1994-04-08
MX9305769A (en) 1994-05-31
ZA937321B (en) 1994-04-25

Similar Documents

Publication Publication Date Title
AU5115393A (en) Novel derivatives of taxol analogues, preparation thereof and compositions containing them
AU2388092A (en) New derivatives of taxol analogues, preparation thereof and compositions containing them
AU1914092A (en) Novel derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them
ZA94342B (en) C2 Taxane derivatives and pharmaceutical compositions containing them
AU7227587A (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU2002792A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
AU3181689A (en) Thienopyridines, preparation, intermediates and pharmaceutical compositions
AU2951489A (en) Improving the stability of pharmaceutical compositions
AU5339594A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
ZA938366B (en) Process for the preparation of taxane derivatives new taxanes thereby obtained and compositions containing them
AU3505093A (en) Novel baccatine III and 10-deacetyl baccatine III derivatives, their preparation, and pharmaceutical compositions containing same
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
AU2392392A (en) Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use
AU2024388A (en) Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
AU4618989A (en) 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them
HUT67014A (en) Benzofuran derivatives, pharmaceutical compositions containing them and process for the preparation of thereof
AU7230194A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
AU8147094A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU3503093A (en) Novel adenosine derivatives, their preparation methods and pharmaceutical compositions containing same
AU4075893A (en) Novel taxane derivatives, their preparation and compositions containing same
AU8146994A (en) Novel taxicine derivatives, their preparation and pharmaceutical compositions containing them
AU6787994A (en) Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
IL108632A0 (en) Fluorinated 4-aminoandrostadienone derivatives, their preparation and pharmaceutical compositions containing them
AU4573793A (en) N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them